Trial intelligence / Profile preview

Desflurane-propofol vs Desflurane anesthesia for FVEP monitoring

NCT05465330Completed

Sponsor
Beijing Tiantan Hospital
Start
Jul 2022
Primary completion
Apr 2023
Modality
Allosteric Modulators
Countries
1
01

Overview

Randomised, open-label trial of desflurane (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: N75-p100 amplitude value. Started Jul 2022; status: completed.

02

Drugs

desflurane

Beyond the preview

Go deeper on NCT05465330.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05465330.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call